Hrvoje Gašparović

Dr. Hrvoje Gašparović


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2024 in European Heart Journal
Verified
Journal Article
Open access
PDF file
MBMarko Banovic
Marko Banovic
SPSvetozar Putnik
Svetozar Putnik
BCBruno R Da Costa
Bruno R Da Costa
MPMartin Penicka
Martin Penicka
MDMarek A Deja
Marek A Deja
JBJozef Bartunek
Jozef Bartunek
The question of when and how to treat truly asymptomatic patients with severe aortic stenosis (AS) and normal left ventricular (LV) systolic function is still subject to debate and ongoing research. Here, the results of extended follow-up of the AVATAR trial are reported (NCT02436655, ClinicalTrials.gov). The AVATAR trial randomly assigned patients with severe, asymptomatic AS and LV ejection fraction ≥ 50% to undergo either early surgical aortic valve replacement (AVR) or conservative treatment with watchful waiting strategy. All patients had negative exercise stress testing. The primary hypothesis was that early AVR will reduce a primary composite endpoint comprising all-cause death, acute myocardial infarction, stroke, or unplanned hospitalization for heart failure (HF), as compared with conservative treatment strategy. A total of 157 low-risk patients (mean age 67 years, 57% men, mean Society of Thoracic Surgeons score 1.7%) were randomly allocated to either the early AVR group (n = 78) or the conservative treatment group (n = 79). In an intention-to-treat analysis, after a median follow-up of 63 months, the primary composite endpoint outcome event occurred in 18/78 patients (23.1%) in the early surgery group and in 37/79 patients (46.8%) in the conservative treatment group [hazard ratio (HR) early surgery vs. conservative treatment 0.42; 95% confidence interval (CI) 0.24–0.73, P = .002]. The Kaplan–Meier estimates for individual endpoints of all-cause death and HF hospitalization were significantly lower in the early surgery compared with the conservative group (HR 0.44; 95% CI 0.23–0.85, P = .012, for all-cause death and HR 0.21; 95% CI 0.06–0.73, P = .007, for HF hospitalizations). The extended follow-up of the AVATAR trial demonstrates better clinical outcomes with early surgical AVR in truly asymptomatic patients with severe AS and normal LV ejection fraction compared with patients treated with conservative management on watchful waiting. The design and main result of the AVATAR randomized trial (intention-to-treat population). AMI, acute myocardial infarction; CI, confidence interval; HF, heart failure; HR, hazard ratio; LV, left ventricular.

10 April 2014 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
HGHrvoje Gašparović
Hrvoje Gašparović
MCMaja Cikes
Maja Cikes
TKTomislav Kopjar
Tomislav Kopjar
LHLjiljana Hlupic
Ljiljana Hlupic
VVVedran Velagic
Vedran Velagic
BBBojan Biočina
Bojan Biočina
Chronic atrial volume overload and atrial fibrillation (AF) induce structural changes within atrial myocardium. The aim of this study was to evaluate the effect of adverse cellular remodelling on echocardiographic strain rate (SR) deformation indices of atrial contractile, conduit and reservoir functions. Forty-four consecutive patients with organic mitral regurgitation were analysed. Twenty-eight patients had long-standing persistent AF (AF group), while 16 were in normal sinus rhythm (NSR group). Left atrial (LA) samples were harvested from all the patients for histological analysis. Postoperative echocardiographic data acquisition was performed exclusively during organized atrial electrical activity in order to assess the contractile reserve of patients from both groups. Fibrotic atria had inferior conduit (SR-E: r = −0.36, P = 0.017), reservoir (SR-S: r = −0.31, P = 0.041) and contractile functions (SR-A: r = −0.33, P = 0.027). Analogously, atria with greater apoptotic burdens showed a negative correlation with multiple indices of left atrial functions (SR-E: r = −0.38, P = 0.010; SR-S: r = −0.33, P = 0.028; SR-A: r = −0.28, P = 0.067). The efficiency of atrial contractility was significantly reduced among AF-group patients after conversion to sinus rhythm, when compared with patients in the NSR group (LA active emptying fraction: 20 ± 12 vs 30 ± 10%, P = 0.004; SR-A: 1.1 ± 1.0 vs 2.8 ± 1.9 s−1, P < 0.001). Superior strain-rate indices of atrial conduit and reservoir functions were noted in the NSR group (SR-E: 3.5 ± 2.3 vs 1.3 ± 1.0 s−1, P < 0.001; LA expansion index: 86 ± 31 vs 60 ± 42%, P = 0.004). Fibrosis was evident in 7.2 [3.3;9.4]% of the LA tissue sample in the AF group, while it accounted for 3.4 [1.2;8.1]% of atrial tissue in the NSR group (P = 0.054). Apoptosis was documented in 13 (46%) patients in the AF group, whereas none of the patients in the NSR group exhibited signs of programmed cell death (P = 0.001). Myocyte degeneration was more prevalent in the AF group (odds ratio: 7.0, 95% confidence interval: 1.3–36.7, P = 0.021). Age showed a positive correlation with worsening degrees of atrial fibrosis and apoptosis (r = 0.41, P = 0.006; r = 0.49, P = 0.001, respectively). Multiple regression analysis identified SR-S (β = −1.263, P = 0.036) and age (β = 0.144, P = 0.057) as independent predictors of fibrosis. Independent determinants of apoptosis were preoperative AF (β = 4.539, P = 0.007), age (β = 0.188, P = 0.009) and SR-S (β = −1.780, P = 0.002). Atria exhibiting greater fibrotic and apoptotic burdens had impaired conduit, reservoir and contractile function, as evaluated by deformation imaging. Among patients with chronic LA volume overload, exposure to long-standing persistent AF induced more pronounced degrees of adverse atrial cellular remodelling. Strain-rate descriptors of atrial reservoir function harboured potential to predict atrial fibrosis and apoptosis.

1 August 2017 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
HGHrvoje Gašparović
Hrvoje Gašparović
TKTomislav Kopjar
Tomislav Kopjar
DSDiyar Saeed
Diyar Saeed
MCMaja Cikes
Maja Cikes
LSLucija Svetina
Lucija Svetina
BBBojan Biocina
Bojan Biocina

1 May 2014 in The American Journal of Cardiology
Verified
Journal Article
Open access
HGHrvoje Gašparović
Hrvoje Gašparović
MPMate Petričević
Mate Petričević
TKTomislav Kopjar
Tomislav Kopjar
ZDZeljko Djuric
Zeljko Djuric
LSLucija Svetina
Lucija Svetina
BBBojan Biocina
Bojan Biocina
Coronary artery bypass grafting is pivotal in the contemporary management of complex coronary artery disease. Interpatient variability to antiplatelet agents, however, harbors the potential to compromise the revascularization benefit by increasing the incidence of adverse events. This study was designed to define the impact of dual antiplatelet therapy (dAPT) on clinical outcomes among aspirin-resistant patients who underwent coronary artery surgery. We randomly assigned 219 aspirin-resistant patients according to multiple electrode aggregometry to receive clopidogrel (75 mg) plus aspirin (300 mg) or aspirin-monotherapy (300 mg). The primary end point was a composite outcome of all-cause death, nonfatal myocardial infarction, stroke, or cardiovascular hospitalization assessed at 6 months postoperatively. The primary end point occurred in 6% of patients assigned to dAPT and 10% of patients randomized to aspirin-monotherapy (relative risk 0.61, 95% confidence interval 0.25 to 1.51, p = 0.33). No significant treatment effect was noted in the occurrence of the safety end point. The total incidence of bleeding events was 25% and 19% in the dAPT and aspirin-monotherapy groups, respectively (relative risk 1.34, 95% confidence interval 0.80 to 2.23, p = 0.33). In the subgroup analysis, dAPT led to lower rates of adverse events in patients with a body mass index >30 kg/m(2) (0% vs 18%, p <0.01) and those <65 years (0% vs 10%, p = 0.02). In conclusion, the addition of clopidogrel in patients found to be aspirin resistant after coronary artery bypass grafting did not reduce the incidence of adverse events, nor did it increase the number of recorded bleeding events. dAPT did, however, lower the incidence of the primary end point in obese patients and those <65 years.

1 April 2019 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
HGHrvoje Gašparović
Hrvoje Gašparović
TKTomislav Kopjar
Tomislav Kopjar
MRMilan Rados
Milan Rados
AAAlan Anticevic
Alan Anticevic
MRMarko Rados
Marko Rados
BBBojan Biocina
Bojan Biocina

1 July 2011 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
HGHrvoje Gašparović
Hrvoje Gašparović
ZDZeljko Djuric
Zeljko Djuric
DBDubravka Bosnic
Dubravka Bosnic
MPMate Petričević
Mate Petričević
MBMargita Brida
Margita Brida
BBBojan Biocina
Bojan Biocina